Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Apply temporary budget tweaks to handle short-term shifts. Explore flexible options that protect essentials while reducing non-essentials.
14,253 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
OpenAI's Sam Altman defended AI energy use at a major industry summit, arguing the footprint must be viewed against h...
A practical, easy-to-follow look at ryman hospitality (rhp) earnings. Learn the key metrics, what the latest call sig...
Home Depot reported a softer finish to 2025 with earnings beating expectations but signaling broad headwinds from a c...
Northeast metros are clearing supply faster than many Sun Belt peers, boosting seller leverage as spring demand retur...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...
Mexico advances a phased plan to cut the standard workweek from 48 to 40 hours by 2030, with a gradual two-hour reduc...
Solventum wraps up 2025 with meaningful growth and a clearer path to profitability. This article breaks down the numb...
Tech stocks can be volatile but offer big upside for patient investors. This guide explores a low-cost Vanguard ETF a...
Thinking about owner financing on your rental sale? This guide breaks down why a never seller financing deal can back...
When a top executive at Yum China sells a large block of stock, investors pay attention. This article breaks down the...
The leader of america’s largest social security advisory firm argues that the Trump-era tax cuts failed to shore up S...